Deep Dive: Drug Prices and Access to Medicine

The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach for countess ailing people, including many with decent insurance. The industry argues that it needs the revenue for the complex and expensive research that leads to better treatments, but pharmaceutical executives are being pilloried in editorials and Congressional hearings, and consumer groups say marketing and profit are the real drivers of price. What’s behind the cost of drugs? What are the options for people who can’t pay it?

Festival: Aspen Ideas 2016

More on this Session

Watch and Listen: Science

Those who study human behavior have learned that simply by encouraging—or “nudging”—individuals toward the right... See more
Published studies have documented the many physical and mental health benefits of meditation, including decreased pain... See more
Medicine is being disrupted from every angle, as the financing and organization of clinical care are overhauled and... See more
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs... See more
Technology is transforming how we provide medical care, improve diagnostics, share information, and extend the reach of... See more

Pages